“Stimulant Use: Harm Reduction, Treatment, and Future Directions” Conference Report Available

In September 2017, the Drug Policy Alliance organized a conference in Los Angeles in partnership with over a dozen organizations, including the Center for Behavioral and Addiction Medicine (CBAM), titled “Stimulant Use: Harm Reduction, Treatment, and Future Directions.” The conference aimed to bring attention to a large class of drugs that has received inconsistent attention from the media, harm reduction and treatment communities, researchers, and policymakers alike. Los Angeles was chosen for this conference due to its sustained and high prevalence of use of stimulants both historically and currently.

CBAM’s Dr. Steven Shoptaw joined the panel discussion on treatment options for people who use stimulants. For a full report of the conference, click this link.


CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.